When coupled with a low serum AFP concentration (<400 μg/L) and a consistent Ki-67 index, upregulation of CK-19 can be a powerful additional prognostic indicator for use in patients with HBV-related HCC undergoing radical resection. This evidence concerns the gene KRT19 and hepatocellular carcinoma.